Orthofix International | OFIX - Operating Expenses

Stock Price
12.85
Daily Change
0.13 1.02%
Monthly
8.26%
Yearly
-0.85%
Q2 Forecast
12.04

Orthofix International reported $213.79M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Accuray USD 37.18M 567K Dec/2024
AngioDynamics USD 81.95M 1.68M Sep/2025
Artivion USD 111.2M 9.45M Dec/2025
AtriCure USD 138.01M 3.95M Dec/2025
Dexcom USD 936.6M 30.2M Dec/2025
EDAP TMS EUR 18.8M 3.01M Sep/2025
Globus Medical USD 645.11M 241.46M Dec/2025
Inogen USD 49.14M 665K Sep/2024
Insulet USD 637.5M 48.9M Dec/2025
Integra LifeSciences USD 368.92M 668.65M Dec/2025
J&J USD 17.44B 1.53B Mar/2026
Medtronic USD 7.28B 16M Dec/2025
Mesa Laboratories USD 33.98M 2.03M Dec/2024
Orthofix International USD 213.79M 12.36M Dec/2025
Plus Therapeutics USD 7.11M 1.23M Dec/2025
Smith & Nephew USD 2.52B 84M Dec/2025
STAAR Surgical USD 68.74M 1.55M Dec/2025
Stryker USD 5.2B 505M Dec/2025
Surmodics USD 29.51M 274.86M Jun/2025
Tandem Diabetes Care USD 282.09M 9.97M Dec/2025
Teleflex USD 532.64M 3.29B Dec/2025
Veracyte USD 116M 7.24M Dec/2025
Zimmer Biomet Holdings USD 1.94B 277.8M Dec/2025